Article

Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate Cancer

2023-04-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The benefits of prostate cancer screening with serum prostate-specific antigen (PSA) have been largely offset by the high rate of negative prostate biopsies and overdiagnosis of indolent cancers. These outcomes result from the limited diagnostic accuracy of PSA for clinically significant prostate cancer and are considered a major obstacle to realizing the benefits of populatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf756902-a72f-52d5-b127-3b6b5b9ae03f
DOI: 10.1101/2023.04.11.23288418

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate CancerDOI 10.1101/2023.04.11.23288418Read

A Urine-Based Exosomal Gene Expression Test Stratifies Risk of High-Grade Prostate Cancer in Men with Prior Negative Prostate Biopsy Undergoing Repeat BiopsySemantic proximity Read

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detectionSemantic proximity Read

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patientsSemantic proximity Read

Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patientsSemantic proximity Read

Optimizing Detection of Clinically Significant Prostate Cancer through Nomograms incorporating MRI, Clinical Features, and Advanced Serum BiomarkersSemantic proximity Read

Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseaseSemantic proximity Read

Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate CancerSemantic proximity Read

Large‐scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levelsSemantic proximity Read

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.Semantic proximity Read

A Minimal Plasma Proteome-Based Biomarker Panel for Accurate Prostate Cancer DiagnosisSemantic proximity Read

Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosisSemantic proximity Read

Identification of Biomarkers and Trajectories of Prostate Cancer Progression: A Bioinformatics Fusion of Weighted Correlation Network Analysis and Machine LearningSemantic proximity Read